BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3896704)

  • 1. Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis.
    Blumer JL; Aronoff SC; Myers CM; O'Brien CA; Klinger JD; Reed MD
    Dev Pharmacol Ther; 1985; 8(4):219-31. PubMed ID: 3896704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
    Kaplan SL; Mason EO; Garcia H; Kvernland SJ; Loiselle EM; Anderson DC; Mintz AA; Feigin RD
    J Pediatr; 1981 Jan; 98(1):152-7. PubMed ID: 6450278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bacterial meningitis with ceftazidime.
    Hatch D; Overturf GD; Kovacs A; Forthal D; Leong C
    Pediatr Infect Dis; 1986; 5(4):416-20. PubMed ID: 3523458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial meningitis. Effect of antibiotic treatment on cerebrospinal fluid.
    Blazer S; Berant M; Alon U
    Am J Clin Pathol; 1983 Sep; 80(3):386-7. PubMed ID: 6881104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of ceftazidime in the cerebrospinal fluid].
    Decazes JM
    Presse Med; 1988 Oct; 17(37):1914-6. PubMed ID: 2973584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid penetration of cefmenoxime in children with bacterial meningitis.
    Eicken A; Schöber JG; Roos R; Machka K
    Infection; 1991; 19(6):406-8. PubMed ID: 1816111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations.
    Rodriguez WJ; Puig JR; Khan WN; Feris J; Gold BG; Sturla C
    Pediatr Infect Dis; 1986; 5(4):408-15. PubMed ID: 3523457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam for the treatment of bacterial meningitis in children.
    Freedman JM; Hoffman SH; Scheld WM; Lynch MA; da Silva HR; Rocha H; Sande MA
    J Infect Dis; 1983 Nov; 148(5):886-91. PubMed ID: 6415181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibilities of perfecting antimicrobial therapy. Dynamics of penicillin G concentrations in the cerebro-spinal fluid in purulent meningitis.
    Căruntu F; Streinu-Cercel A; Căruntu V; Angelescu C
    Med Interne; 1990; 28(2):157-62. PubMed ID: 2270425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis.
    Lin TY; Chrane DF; Nelson JD; McCracken GH
    JAMA; 1985 Jun; 253(24):3559-63. PubMed ID: 3889396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.
    Barson WJ; Miller MA; Brady MT; Powell DA
    Pediatr Infect Dis; 1985; 4(4):362-8. PubMed ID: 3895175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed cerebrospinal fluid sterilization in infants with Hemophilus influenzae type b meningitis.
    Hatch DL; Overturf GD
    J Infect Dis; 1989 Oct; 160(4):711-5. PubMed ID: 2677164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The penetration of broad-spectrum antibiotics into the cerebrospinal fluid.
    Taber LH; Yow MD; Nieberg FG
    Ann N Y Acad Sci; 1967 Sep; 145(2):473-81. PubMed ID: 4397885
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.
    del Rio Mde L; Chrane DF; Shelton S; McCracken GH; Nelson JD
    Antimicrob Agents Chemother; 1982 Dec; 22(6):990-4. PubMed ID: 7159072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins E2 and I2, interleukin 1-beta, and tumor necrosis factor in cerebrospinal fluid in infants and children with bacterial meningitis.
    Mustafa MM; Ramilo O; Sáez-Llorens X; Mertsola J; Magness RR; McCracken GH
    Pediatr Infect Dis J; 1989 Dec; 8(12):921-2. PubMed ID: 2516624
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children.
    del Rio MA; Chrane D; Shelton S; McCracken GH; Nelson JD
    Lancet; 1983 Jun; 1(8336):1241-4. PubMed ID: 6134039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin treatment of bacterial meningitis in children.
    Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
    Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.